首頁 > 市場調查報告書 > 醫療設備

測量儀器生技設備

CRO質譜服務市場規模、佔有率和成長分析：按服務類型、儀器類型、應用、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2048631

CRO質譜服務市場規模、佔有率和成長分析：按服務類型、儀器類型、應用、最終用戶和地區分類－2026-2033年產業預測

CRO Mass Spectroscopy Services Market Size, Share, and Growth Analysis, By Service Type (Metabolomics, Proteomics), By Instrument Type (Quadrupole MS, TOF (Time-of-Flight)), By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球 CRO 質譜服務市場價值 35.2 億美元，預計到 2025 年將成長至 38.3 億美元，到 2033 年將成長至 75.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.82%。

全球CRO質譜服務市場的主要驅動力是製藥和生技公司對高解析度、高通量分析解決方案日益成長的需求。這些公司依賴合約研究組織（CRO）提供的專業質譜服務涵蓋ADME、毒性測試、藥物動力學和生物標記分析等領域。此外，企業內部購置先進設備和掌握專業技術的成本高昂，也進一步推動了市場成長。隨著時間的推移，該市場不斷發展，從簡單的分子分析發展到更複雜的技術，例如蛋白質組分析和成像質譜。此外，隨著委託公司致力於開發先進的生物製藥和藥物，CRO提供的全面、端到端的分析工作流程正透過製藥公司增加專案外包，顯著推動市場成長，從而提升整體市場收入。

全球CRO質譜服務市場的促進因素

全球CRO質譜服務市場的主要促進因素之一是製藥和生物技術產業對先進分析技術日益成長的需求。隨著這些行業不斷創新和開發複雜分子，對化合物進行準確可靠的表徵以確保其有效性和安全性的需求也日益增加。此外，將分析服務外包給CRO（合約研究組織）的趨勢日益成長，也推動了質譜服務的成長，因為企業可以利用尖端技術和專業知識，同時專注於其核心業務。這種專業化趨勢提高了營運效率，並加快了藥物發現和開發進程。

全球CRO質譜服務市場的限制因素

全球CRO質譜服務市場的主要限制因素之一是先進質譜技術和服務的高成本。購置精密設備、持續維護和聘請專業人員所需的大量投資，可能會阻礙中小企業和研究機構使用這些服務。此外，質譜技術的複雜性可能需要對員工進行全面的培訓，這會進一步增加成本。因此，預算限制了製藥、環境檢測和食品安全等領域的潛在客戶獲取這些服務，最終阻礙了質譜服務市場的成長和創新。

全球CRO質譜服務市場趨勢

全球CRO質譜服務市場正呈現出整合多體學方法顯著發展的趨勢。客戶日益尋求能夠整合多種體學學科（例如蛋白質組學和代謝體學）並結合先進的樣品製備技術和強大的生物資訊分析的綜合解決方案。這種不斷成長的需求正促使合約研究組織（CRO）拓展服務範圍，並加強合作以提升其技術能力。為因應這一趨勢，CRO正致力於客製化檢測方法開發、嚴格的品管措施以及詳盡的報告服務，旨在支持藥物發現和轉化研究，最終為科學創新和知識進步做出貢獻。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Thermo Fisher Scientific（PPD）
Covance（Labcorp Drug Development）
ICON plc
PRA Health Sciences
WuXi AppTec
Charles River Laboratories
SGS SA
Intertek
Eurofins Scientific
Pace Analytical（GEL Laboratories）
BioAgilytix
BioPharma Finder
Pacific BioLabs
Q2 Solutions（IQVIA）
Quotient Bioresearch

結論與建議

簡介目錄

Product Code: SQMIG35J2280

Global Cro Mass Spectroscopy Services Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 7.52 Billion by 2033, growing at a CAGR of 8.82% during the forecast period (2026-2033).

The global CRO mass spectrometry services market is primarily driven by the increasing demand for high-resolution and high-throughput analytical solutions from pharmaceutical and biotechnology firms. These organizations rely on contract research organizations for specialized mass spectrometry services that encompass ADME, toxicology testing, pharmacokinetics, and biomarker analysis. The high costs associated with replicating advanced equipment and expertise further bolster this market, which has evolved over time from simple small molecule analysis to complex techniques such as proteoform analysis and imaging mass spectrometry. Additionally, as sponsors seek to develop advanced biologics and drugs, the provision of comprehensive, end-to-end analytical workflows by CROs is fostering significant growth through increased project outsourcing by pharmaceutical companies, enhancing overall market revenues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cro Mass Spectroscopy Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cro Mass Spectroscopy Services Market Segments Analysis

Global CRO mass spectroscopy services market is segmented by service type, instrument type, application, end-user and region. Based on service type, the market is segmented into Metabolomics, Proteomics, Drug Metabolism & Pharmacokinetics (DMPK), Lipidomics and Others. Based on instrument type, the market is segmented into Quadrupole MS, TOF (Time-of-Flight), Orbitrap and Triple Quadrupole. Based on application, the market is segmented into Drug Discovery, Biomarker Discovery and Clinical Research. Based on end-user, the market is segmented into Pharma Companies, Biotech Companies and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cro Mass Spectroscopy Services Market

One of the key market drivers for the global CRO mass spectroscopy services market is the increasing demand for advanced analytical techniques in pharmaceutical and biotechnology sectors. As these industries continue to innovate and develop complex molecules, there is a growing need for precise and reliable characterizations of compounds to ensure efficacy and safety. Furthermore, the rising trend of outsourcing analytical services to contract research organizations (CROs) allows companies to focus on core activities while accessing cutting-edge technologies and expert knowledge, thereby fueling the growth of mass spectroscopy services. This shift towards specialization enhances operational efficiencies and accelerates drug development timelines.

Restraints in the Global Cro Mass Spectroscopy Services Market

One of the key market restraints for the global CRO mass spectroscopy services market is the high cost associated with advanced mass spectroscopy technologies and services. The significant investment required for sophisticated equipment, ongoing maintenance, and skilled personnel can deter smaller companies and research institutions from utilizing these services. Additionally, the complexity of mass spectroscopy methods may necessitate extensive training for staff, further driving up costs. As a result, budget constraints may limit access for potential clients in various sectors, including pharmaceuticals, environmental testing, and food safety, ultimately hindering market growth and innovation in mass spectroscopy services.

Market Trends of the Global Cro Mass Spectroscopy Services Market

The Global CRO Mass Spectroscopy Services market is witnessing a significant trend towards the adoption of integrated multiomics approaches. Clients increasingly seek comprehensive solutions that combine various omic fields, such as proteomics and metabolomics, along with sophisticated sample preparations and robust bioinformatics analyses. This rising demand encourages Contract Research Organizations (CROs) to diversify their service offerings and foster collaborations to enhance their technical capabilities. In response to this trend, CROs are focusing on providing bespoke assay development, stringent quality control measures, and detailed reporting services aimed at supporting both discovery and translational research, ultimately advancing scientific innovation and insights.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global CRO Mass Spectroscopy Services Market Size by Service Type & CAGR (2026-2033)

Market Overview
Metabolomics
Proteomics
Drug Metabolism & Pharmacokinetics (DMPK)
Lipidomics
Others

Global CRO Mass Spectroscopy Services Market Size by Instrument Type & CAGR (2026-2033)

Market Overview
Quadrupole MS
TOF (Time-of-Flight)
Orbitrap
Triple Quadrupole

Global CRO Mass Spectroscopy Services Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Biomarker Discovery
Clinical Research

Global CRO Mass Spectroscopy Services Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharma Companies
Biotech Companies
Research Institutes

Global CRO Mass Spectroscopy Services Market Size & CAGR (2026-2033)

North America (Service Type, Instrument Type, Application, End-User)
- US
- Canada
Europe (Service Type, Instrument Type, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service Type, Instrument Type, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service Type, Instrument Type, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Service Type, Instrument Type, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (PPD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance (Labcorp Drug Development)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical (GEL Laboratories)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioPharma Finder
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific BioLabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Q2 Solutions (IQVIA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quotient Bioresearch
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments